CareDx, Inc. Goodwill & Intangibles Disclosure
| December 31, 2025 | |||||||||||||||||||||||||||||
| Gross Carrying Amount | Accumulated Amortization | Foreign Currency Translation | Net Carrying Amount | Weighted Average Remaining Useful Life (In Years) | |||||||||||||||||||||||||
| Intangible assets with finite lives: | |||||||||||||||||||||||||||||
| Acquired and developed technology | $ | 36,517 | $ | (24,127) | $ | (2,203) | $ | 10,187 | 5.8 | ||||||||||||||||||||
| Customer relationships | 25,581 | (12,413) | (1,639) | 11,529 | 7.1 | ||||||||||||||||||||||||
| Commercialization rights | 11,579 | (7,022) | — | 4,557 | 3.6 | ||||||||||||||||||||||||
| Trademarks and tradenames | 4,860 | (2,434) | (232) | 2,194 | 6.6 | ||||||||||||||||||||||||
| Total intangible assets with finite lives | 78,537 | (45,996) | (4,074) | 28,467 | |||||||||||||||||||||||||
Intangible assets with indefinite lives: | |||||||||||||||||||||||||||||
| Acquired in-process technology | 1,250 | — | — | 1,250 | |||||||||||||||||||||||||
| Favorable license agreement | 2,243 | — | — | 2,243 | |||||||||||||||||||||||||
| Total intangible assets with indefinite lives | 3,493 | — | — | 3,493 | |||||||||||||||||||||||||
| Total intangible assets | $ | 82,030 | $ | (45,996) | $ | (4,074) | $ | 31,960 | |||||||||||||||||||||
| December 31, 2024 | |||||||||||||||||||||||||||||
| Gross Carrying Amount | Accumulated Amortization | Foreign Currency Translation | Net Carrying Amount | Weighted Average Remaining Useful Life (In Years) | |||||||||||||||||||||||||
| Intangible assets with finite lives: | |||||||||||||||||||||||||||||
| Acquired and developed technology | $ | 37,367 | $ | (21,357) | $ | (2,531) | $ | 13,479 | 6.6 | ||||||||||||||||||||
| Customer relationships | 25,718 | (10,777) | (2,332) | 12,609 | 8.4 | ||||||||||||||||||||||||
| Commercialization rights | 11,579 | (5,760) | — | 5,819 | 4.6 | ||||||||||||||||||||||||
| Trademarks and tradenames | 5,220 | (2,094) | (356) | 2,770 | 8.5 | ||||||||||||||||||||||||
| Total intangible assets with finite lives | 79,884 | (39,988) | (5,219) | 34,677 | |||||||||||||||||||||||||
| Acquired in-process technology | 1,250 | — | — | 1,250 | |||||||||||||||||||||||||
| Favorable license agreement | 2,257 | — | — | 2,257 | |||||||||||||||||||||||||
| Total intangible assets with indefinite lives | 3,507 | — | — | 3,507 | |||||||||||||||||||||||||
| Total intangible assets | $ | 83,391 | $ | (39,988) | $ | (5,219) | $ | 38,184 | |||||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Cost of testing services | $ | 1,388 | $ | 1,316 | $ | 1,316 | |||||||||||
| Cost of product | 1,751 | 1,660 | 1,655 | ||||||||||||||
| Cost of patient and digital solutions | 610 | 850 | 1,039 | ||||||||||||||
| Sales and marketing | 2,602 | 2,520 | 2,457 | ||||||||||||||
| Total | $ | 6,351 | $ | 6,346 | $ | 6,467 | |||||||||||
| Years Ending December 31, | Total | |||||||
| 2026 | $ | 5,332 | ||||||
| 2027 | 5,319 | |||||||
| 2028 | 5,319 | |||||||
| 2029 | 4,604 | |||||||
| 2030 | 3,535 | |||||||
| Thereafter | 4,358 | |||||||
| Total future amortization expense | $ | 28,467 | ||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 27, 2023 | |
| 2021 | Feb 24, 2022 | |
| 2020 | Feb 24, 2021 | |
| 2019 | Feb 28, 2020 | |
| 2018 | Mar 6, 2019 | |
| 2017 | Mar 22, 2018 | |
| 2016 | Apr 21, 2017 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.